Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Researchers discover how rheumatoid arthritis causes bone loss
Slashdot It! Slashdot Researchers discover how rheumatoid arthritis causes bone loss
Submit to Reddit Submit Researchers discover how rheumatoid arthritis causes bone loss to Reddit
Reading: Researchers discover how rheumatoid arthritis causes bone lossTwitter This Reading: Researchers discover how rheumatoid arthritis causes bone lossTwitter Researchers discover how rheumatoid arthritis causes bone loss
Add to Facebook Add Researchers discover how rheumatoid arthritis causes bone loss to Facebook

Researchers discover how rheumatoid arthritis causes bone loss

August 21, 2008

Study results hold implications of autoimmune disease and osteoporosis

Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.




Two million Americans suffer from rheumatoid arthritis (RA), which causes swelling, pain and deformity in joints and also lead to the thinning of bone. In autoimmune diseases like RA, the body's disease-fighting immune cells mistakenly identify parts of a person's body as foreign invaders, akin to bacteria, and produce chemicals to destroy them. Among the immune chemicals known to play a central in autoimmune disease is tumor necrosis factor alpha (TNF alpha), which ramps up the production of immune cells and chemicals as part of the body's response to disease. When overproduced in RA patients, TNF alpha signals for the destruction of cartilage and bone.

Beyond its control over immune cells, TNF alpha also influences bone mass. Human bone is continually regenerated to maintain strength. Under the control of signaling molecules which include TNF alpha, two cell types, balanced against each other, make bone recycling possible. Osteoclasts break down aging bone to make way for new bone, while osteoblasts build new bone at the sites where osteoclasts have removed it. Going into the study, the field understood that TNF alpha decreases the number of bone-building osteoblasts, but not how. The current study provides the first direct proof that the TNF alpha affects osteoblasts through an enzyme called Smad Ubiquitin Regulatory Factor 1 (Smurf1), which in turn shuts down two proteins that would otherwise drive bone-building.

While traditional RA drugs like NSAIDs and steroids treat symptoms, a newer class of best-selling drugs (e.g. Humira, Remicade and Enbrel) reverses the disease process by shutting down TNF alpha activity. While the new drugs are effective for many patients, others experience infections and even lymphoma in a few cases. The new drugs are based on bioengineered versions of proteins made by human immune cells called antibodies, and are very expensive to make. Thus, the field has been searching for smaller, simpler chemicals that would be effective, but with lower costs and fewer side effects.

"The significance of our study is that it identifies SMURF1 as the signaling partner through which TNF does damage in RA-related bone loss," said Lianping Xing, Ph.D., assistant professor of Pathology and Laboratory Medicine at the University of Rochester Medical Center. "That has enabled researchers to begin designing small molecule drugs to shut down the action of Smurf 1 and its relatives. Furthermore, since mice engineered to have less Smurf1 expression develop thicker bones, future drugs that shut down Smurf1 may be also useful against more common forms of osteoporosis simply by changing the dose. Of course, this is early-stage work with many obstacles ahead, but it is exciting nonetheless."

Study Details

In the late 1990s, Gerald H. Thomsen, Ph.D., at Stony Brook University in New York discovered that Smurf1 helps to attach a protein tag called ubiquitin to aging proteins in need of disposal. The tag then attracts the attention of cellular machines called proteosomes that degrade proteins.

Xing's team generated two lines of mice - one with high TNF alpha levels and with Smurf1 present, and a second group with high TNF alpha production but no Smurf1. Bone volume and strength of both groups of mice were then examined using a combination of imaging technologies and were compared. Experiments showed that increased TNF alpha levels dramatically decreased the levels of two key factors, Smad1 and Runx2. Both Smad1 and Runx2 signaled to increase the number of bone-building osteoblasts, but only if Smurf1 was present to pass on the signal from TNF alpha.

Genetically engineered mice with the Smurf1 gene removed no longer responded to TNF alpha because Smurf1 was not present to label Smad1 and Runx2 with the ubiquitin destruction tag. As expected, mice with increased TNF alpha had lesser bone mass than their counterparts, a result partially reversed in mice where Smurf1 had been removed.

Bolstering the importance of the current paper is the fact that TNF alpha promotes the destruction of some types of cancer cells. While toxic when administered systemically, it has found a niche in preventing the spread of skin cancer, where it can be injected directly into a tumor. Other drugs then became available that shut down the TNF signal by directly inhibiting the protein-eating proteosomes that receive the signal. There is an existing anti-myeloma drug on the market, bortezomib, which shuts down the proteosomes that Smurf1 partners with to destroy Smad 1 and Runx2.

Thus, Xing's team will be looking at the effect of bortezomib over the next year to see if shutting down proteosomes in bone cells does indeed increase bone mass in mice engineered to have high levels of TNF alpha. Bortezomib, is a general proteosome inhibitor, however, and does not specifically target Smurf 1, and future efforts will seek to identify Smurf1-specific drug candidates. In the meantime, the team is also seeking other groups of ligases that, like Smurf1, contribute to bone loss because experiments revealed that Smurf1 is not responsible for 100 percent of the bone loss under inflammatory conditions.

Along with Xing, the study was led by Ruolin Guo, Motozo Yamashita, Qian Zhang, Quan Zhou, Di Chen, David G. Reynolds, Hani Awad, Laura Yanoso, Lan Zhao, Edward Schwarz, Ying Zhang and Brendan Boyce within the Department of Pathology at University of Rochester. The article published today in hard copy was first published online on June 19, 2008.

"Our over-all hypothesis is that in inflammatory diseases like RA, the function of a group of enzymes like Smurf1 gets turned on to cause proteasome degradation of key regulator proteins leading to bone loss," Xing said. "The real, future solution will involve a treatment that specifically addresses each of these."

University of Rochester Medical Center





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Biofilm   Atrial Fibrillation   Volcanic Eruptions   Climate models   Atherosclerosis   Liver Injury   Self-esteem   Wetlands   Black Hole   Oxytocin   Kidney Disease   Combination Therapy   Aspirin   Pre-eclampsia   Rheumatoid Arthritis   Volcano   Carbon Dioxide   Stem Cell   Dietary Supplements   Gamma Ray   Robotic Surgery   Fingerprint   Eating Disorders   Flu Virus   Type 2 Diabetes  
Related Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News Articles Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News RSS Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News RSS
Gene expression findings a step toward better classification and treatment of juvenile arthritis
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA).

New trigger for chronic inflammation in rheumatoid arthritis discovered
A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis.

Structures from the human immune system's oldest branch shed light on a range of diseases
How molecules of the oldest branch of the human immune system have interconnected has remained a mystery.

Psoriasis associated with cardiovascular disease and increased mortality
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death.

Early treatment of systemic onset JIA with anakinra restores the IL-18 response
First line treatment with anakinra (an interleukin-1 (IL-1) receptor antagonist), results in a 'good' clinical response (ACRp90) in patients newly diagnosed with systemic onset juvenile idiopathic arthritis (SoJIA), and restores the deficient IL-18 response of natural killer (NK) cells.

RA individuals from lower GDP countries keep working despite worse symptoms than richer countries
Individuals diagnosed with rheumatoid arthritis (RA) in lower gross domestic product (GDP) countries (GDP below $11,000) are more likely to continue working despite higher disease activity and functional disability scores compared to their counterparts in higher GDP countries (GDP >$24,000).

Aussie and Kiwi researchers make double MS genetic discovery
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.

New treatment strategy offers hope to RA patients who failed all other therapies
Rheumatoid arthritis (RA) patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months.

Diagnosis of arthritis 5 years earlier in childless women compared to those with children
Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children).

63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely
Over half (63%) of patients with rheumatoid arthritis (RA) also suffer from psychiatric disorders, with the majority of these (87%) occurring in the depressive spectrum.
More Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News Articles
The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed (First Year, The)

The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed (First Year, The)
by M.E.A. McNeil (Author), Kenneth Sack MD (Foreword)

Rheumatoid arthritis (RA), a disease characterized by inflammation of the joints, is one of the most disabling forms of arthritis and affects over two million people in the United States. Without proper treatment it can lead to long-term joint damage, chronic pain, loss of function, and disability. From the first moment of her diagnosis, author M.E.A. McNeil took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step-by-step through their first year with RA. McNeil provides crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, emotional issues, networking with others, and much more. The First Year—Rheumatoid Arthritis is an essential resource for everyone who wants...

Synova Total Joint Care with Glucosamine, Chondroitin, MSM for Osteo and Rheumatoid Arthritis - 60 Coated Caplets

Synova Total Joint Care with Glucosamine, Chondroitin, MSM for Osteo and Rheumatoid Arthritis - 60 Coated Caplets
by Next Nutraceuticals

Synova Total Joint Care provides the latest clinically tested ingredients for the body's moveable joints, called synovial joints. The shoulder, elbow, wrist, fingers, hip, knee, ankle and toes are synovial joints. Synova Total Joint Care works to support joint health as well as joint flare-ups.* *Glucosamine HCl - a precursor for glycosaminoglycans, the primary component of joint cartilage. Glucosamine can help rebuild, renew and strengthen synovial joint cartilage.* *Joint Serum (Hyaluronic Acid) - HA is a natural component of synovial fluid found to increase joint viscosity, naturally helping to lubricate and re-hydrate joints.* *Methylsulfonylmethane (MSM) - a naturally occuring sulfur needed to form collagen, which is the protein found in all synovial connective...

Living with Rheumatoid Arthritis (Johns Hopkins Press Health Book)

Living with Rheumatoid Arthritis (Johns Hopkins Press Health Book)
by Tammi L. Shlotzhauer MD (Author), James L. McGuire MD (Author), Carol M. Ziminski MD (Foreword)

Already a trusted guide and an invaluable resource, Living with Rheumatoid Arthritis offers practical advice for the millions of people who live with this painful disease. Now thoroughly revised and expanded, this second edition brings readers up to date with the latest methods of diagnosis and treatment.

Building on their accessible explanation of the disease and its causes, the authors describe the essential components of care: medication, joint protection, physical activity, and good nutrition. They provide a wealth of new information on medications, including biologic response–modifiers, alternative and complementary approaches, and treatments for osteoporosis (which often accompanies rheumatoid arthritis), and they describe safe and effective ways to cope with pain,...

Conquering Arthritis: What Doctors Don't Tell You Because They Don't Know: 9 Secrets I Learned the Hard Way

Conquering Arthritis: What Doctors Don't Tell You Because They Don't Know: 9 Secrets I Learned the Hard Way
by Barbara D. Allan (Author)

This book provides hard-earned, practical, detailed information that is critical for successful healing of arthritis, but that has never before been collected in one book. Without this information many people with arthritis will not get well.

The information is organized into a well-researched, easy-to-follow plan for getting well again and includes case histories of people with dramatic and lasting recoveries.

It focuses not just on coping with the symptoms of arthritis, but on correcting its underlying causes using proven alternative medicine and pain management techniques.

Anyone who is serious about healing from arthritis needs this book.

VAXA, Arthritin, A Natural Arthritis Treatment of Rheumatoid Arthritis, Herbal Arthritis ~ 3-60 Capsule bottles

VAXA, Arthritin, A Natural Arthritis Treatment of Rheumatoid Arthritis, Herbal Arthritis ~ 3-60 Capsule bottles
by Vaxa

Arthritin is a natural arthritis treatment specifically formulated to help reduce the pain and discomfort of common arthritis and address three major symptoms of joint degeneration. No other natural arthritis treatment is as comprehensive, or as powerful. Within Arthritin, anti-inflammatory, analgesic and diuretic ingredients create a powerful formula more effective than other brands or than any one ingredient by itself. The ingredients in the natural arthritis treatment have been shown to: 1. Help Reduce pain and inflammation. Protects the production of naturally occurring "pain killers" (endorphins and enkephalins). Blocks pain signals. 2. Help Reduce stiffness. Assists in lessening edema in the joints.

The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed

The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed
by Da Capo Press

Rheumatoid arthritis (RA), a disease characterized by inflammation of the joints, is one of the most disabling forms of arthritis and affects over two million people in the United States. Without proper treatment it can lead to long-term joint damage, chronic pain, loss of function, and disability. From the first moment of her diagnosis, author M.E.A. McNeil took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step-by-step through their first year with RA. McNeil provides crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, emotional issues, networking with others, and much more. The First Year—Rheumatoid Arthritis is an essential resource for everyone who wants...

The New Arthritis Breakthrough: The Only Medical Therapy Clinically Proven to Produce Long-term Improvement and Remission of RA, Lupus, Juvenile RS, Fibromyalgia, ... & Other Inflammatory Forms of Arthritis

The New Arthritis Breakthrough: The Only Medical Therapy Clinically Proven to Produce Long-term Improvement and Remission of RA, Lupus, Juvenile RS, Fibromyalgia, ... & Other Inflammatory Forms of Arthritis
by Henry Scammell (Author)

"...can be miraculous for rheumatoid arthritis sufferers."-- Health & Healing, Tomorrow's Medicine Today

Living With Rheumatoid Arthritis

Living With Rheumatoid Arthritis

Patients with rheumatoid arthritis can suffer immense pain, swelling, stiffness of the joints and fatigue. Once the disease sets in it can involve many joints, be more persistent and cause more disability. Although the cause of rheumatoid arthritis is unknown, experts believe no single reason is responsible and researchers are currently looking at gender and genetics. Rheumatoid arthritis can be a debilitating, crippling disease if not treated, but there is good news. There are new life-changing treatments available to patients today than ever before. Today's new medications, are giving advanced patients a higher level of treatment, ultimately improving their quality of life. In this program we'll hear from patients who've been struggling with pain and fatigue for more than ten years and...

Rheumatoid Arthritis: The Infection Connection {Targeting and Treating the Cause of Chronic Illness}

Rheumatoid Arthritis: The Infection Connection {Targeting and Treating the Cause of Chronic Illness}
by Katherine M. Poehlmann (Author)

Foreword by Dr. Harold W. Clark, author of "Why Arthritis?"

Appendices by Dr. Joseph Mercola (mercola.com) and Dr. Garth Nicolson (Institute for Molecular Medicine)

Definitions of terms

******************************

EVERYTHING YOU NEED TO KNOW BEFORE CONSULTING YOUR DOCTOR!

******************************

A research scientist and former arthritis sufferer outlines a proven treatment that could banish your arthritis pain forever. This well-documented study presents evidence that rheumatoid arthritis (RA) and other chronic illnesses are caused by microbial infection. When the infection triggers allergic reactions, it appears that the body's immune system has turned on itself. Once the cause of the infection and allergies are identified and removed,...

FLA Orthopedics Therall Arthritis Gloves Size Small One Pair

FLA Orthopedics Therall Arthritis Gloves Size Small One Pair
by Florida Orthopedics

Light compression Arthritis Gloves provide therapeutic warmth to reduce pain and swelling. Neoprene material retains the body's natural heat to provide soothing warmth and long-lasting pain relief to aching wrists, fingers and hands. Soft lining wicks moisture away to keep hands dry. Ideal for arthritis, aching fingers, hands or wrists, overuse or repetitive use injuries, Carpal Tunnel Syndrome, and tendonitis. One pair - fits men or women. Color: Beige.

© 2009 BrightSurf.com